Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zoe Kress has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Gissette Reyes-Soffer

    Columbia University Vagelos College of Physicians and Surgeons

    1 shared publication
  • Masanori Aikawa

    The Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, United States

    1 shared publication
  • Nelsa Matienzo

    Columbia University Vagelos College of Physicians and Surgeons, Department of Medicine, Division of Preventive Medicine and Nutrition, 630 West 168th street, P&S 8-503,New York, NY

    1 shared publication
  • Rajesh Kumar Soni

    Proteomics and Macromolecular Crystallography Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA

    1 shared publication
  • Sasha A. Singh

    Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine, Department of Medicine, Brigham Women’s Hospital, Harvard Medical School, Boston, MA, United States

    1 shared publication
  • Yihao Li

    Columbia University Vagelos College of Physicians and Surgeons, Department of Medicine, Division of Preventive Medicine and Nutrition, 630 West 168th street, P&S 8-503,New York, NY

    1 shared publication

Latest Publications

  • Open Access

    Comparative Proteomic Analysis of Lipoprotein(a): Method-Dependent Profiles and Disease Pathways

    by Nelsa Matienzo, Zoe Kress, Sasha A. Singh, Masanori Aikawa, Rajesh K. Soni, Yihao Li, Gissette Reyes-Soffer

    Background: Lipoprotein(a) [Lp(a)] is a genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD). Proteomic studies suggest that Lp(a)-associated proteins mediate inflammation, thrombosis, and vascular calcification, but methodological variability may influence proteome definition. Methods: Lp(a) was immunoprecipitated from human plasma using an apo(a)-specific monoclonal antibody and analyzed by mass spectrometry following either in-gel digestion or automated in-solution proteolysis. Proteins identified by ≥3 unique peptides and consistently detected across all samples by both methods were considered high confidence. Functional enrichment and interaction networks were assessed using STRING. Results: In-solution proteolysis identified 92 proteins and in-gel digestion identified 55 proteins, with 34 proteins shared between methods. These high-confidence proteins were enriched for pathways involved in lipoprotein remodeling, coagulation regulation, vesicle-mediated transport, lipid binding, and extracellular matrix organization, providing biological insight into mechanisms linking Lp(a) to inflammation, thrombosis, and calcification. Conclusions: Proteome composition of Lp(a) is method-dependent; however, a rigorously defined core proteome of 34 proteins was consistently identified across analytical approaches, highlighting biologically relevant pathways that may underlie Lp(a)-mediated ASCVD risk.